GeneDx Holdings (WGS) Acquisitions (2023 - 2025)

GeneDx Holdings (WGS) reported Acquisitions of -$339000.0 for Q4 2025, up 97.21% quarter-over-quarter from -$12.1 million in Q4 2023.

GeneDx Holdings (WGS) Acquisitions (2023 - 2025) Analysis & Trends

GeneDx Holdings (WGS) has 2 years of Acquisitions data on file, last reported at -$339000.0 in Q4 2025.

  • Acquisitions for Q4 2025 came in at -$339000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$339000.0 (up 97.21% YoY), and the FY2025 annual result was $32.9 million, changed N/A from the prior year.
  • Acquisitions improved to -$339000.0 in Q4 2025 per WGS's latest filing, from -$12.1 million in the prior quarter.
  • Over five years, Acquisitions peaked at -$339000.0 in Q4 2025 and troughed at -$12.1 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Waters 29,902.70 Bn 29,902.24 Bn 1.11 Bn 144.00 Mn
2 Thermo Fisher Scientific 175.99 Bn 172.74 Bn 7.74 Bn 8.87 Bn
3 Danaher 129.87 Bn 124.18 Bn 3.59 Bn -
4 Idexx Laboratories 44.75 Bn 44.55 Bn 722.74 Mn -
5 Agilent Technologies 37.52 Bn 35.72 Bn 990.00 Mn -
6 Iqvia Holdings 30.91 Bn 28.94 Bn 1.36 Bn 37.00 Mn
7 Natera 30.21 Bn 29.11 Bn 696.04 Mn -
8 Illumina 24.19 Bn 23.04 Bn 721.00 Mn 415.00 Mn
9 Mettler Toledo International 23.12 Bn 23.06 Bn 555.82 Mn 2.24 Mn
10 GeneDx Holdings 1.52 Bn 1.35 Bn 68.21 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -339,000.00
Dec 31, 2023 -12.14 Mn